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The DICE1 gene consists of 18 exons and contains a 
GpC-rich promoter. 
Transcription 
A major transcript of 4.4 kb and a minor transcript of 
6.9 kb was detected in fetal and adult tissues. In adult 
heart, brain and skeletal muscle an additional smaller 
transcript of 4 kb has been detected by Northern blot 
analysis. The DICE1 cDNA consists of 3665 bp with a 
coding sequence of 2661 bp; an alternatively spliced 
variant generated by skipping of exon 3 has been 
detected specifically in brain. 
Pseudogene 
Presumably LOC285634 at 5p13.1. 
Protein 
Description 
For the DICE1 protein 887 amino acids were predicte. 
A protein of approximately 100 kDaltons was detected 
by coupled in vitro transcription and translation. The 
Int6 protein was purified as an approximately 110 






Mainly nuclear localisation. 
Function 
Predicted motifs of DICE1 protein were a von 
willebrand factor a (VWFA) domain of nuclear 
proteins, nuclear sorting signals and a DEAD box of 
ATP-dependent helicases. Ectopic expression of 
DICE1 cDNA in tumour cells suppresses colony 
formation and in cell culture. The Int6 protein was 
purified as a subunit of a RNA polymerase II 
multiprotein complex with roles in transcriptional 
regulation and RNA processing. 
Homology 
Weak homology to members of the helicase 
superfamily II. 
Mutations 
Note: Mutations in the coding sequence of 
DICE1/DDX26 have been infrequently detected in 
tumour cells. 
Somatic 
Frequent loss of heterozygosity (LOH) has been 
observed in lung, esophageal and prostate carcinomas. 
Promoter hypermethylation concomitant with reduced 
mRNA expression has been observed in lung and 
prostate carcinomas. In esophageal squamous cell 
carcinomas missense mutations V431I, R658Q have 
been detected. In prostate cancer cell line LNCaP 
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Implicated in 
Functional inactivation of the DICE1 gene has been 
implicated in: 
Tumorigenesis of sporadic lung 
carcinomas, esophagus carcinomas, 
prostate carcinomas and possibly other 
sporadic carcinomas 
Abnormal Protein 
A 6.3 kb fusion cDNA of a Notch-like with Dice1 
cDNA (DBI-1) was detected in mouse cell line TC4. 
Overexpression of DBI-1 cDNA in IGF-IR transformed 
mouse cells compromised the mitogenic response to 
IGF-1 and interfered with anchorage-independent 
growth. 
Oncogenesis 
Downregulation of DICE1 mRNA was detected in 7 of 
8 non-small cell lung carcinoma cell lines by Northe n 
blot analysis. Microdissected non-small cell lung 
carcinomas showed reduced or absent expression of 
DICE1 mRNA by RT-PCR. Promoter 
hypermethylation was found in tumour cells with 
downregulated DICE1 expression. Aberrantly sized 
transcripts were detected in two non-small cell lung 
carcinoma cell lines. A reduced DICE1 expression was
also observed in prostate cancer cell lines DU145 and 
LNCaP by real-time RT-PCR. DICE1 promoter 
hypermethylation was detected in 6 of 10 
microdissected prostate cancer samples. Ectopic 
expression of DICE1 cDNA inhibited colony formation 
of human non-small cell lung carcinoma cell lines and 
prostate carcinoma cell lines and suppressed 
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